In agreement with these results, Rouzbauhman et al. found BRAF mutations in 8%, KIT mutations in 28%, NRAS mutations in 28% and TP35 mutations in 8% of vulvar tumors [5]. This evidence concerns the gene BRAF and vulvar neoplasm.